Luminostics awarded NIH RADx contract for rapid COVID-19 test

Luminostics has been awarded a contract by the National Institutes of Health (in collaboration with the Biomedical Advanced Research and Development Authority) under the Rapid Acceleration of Diagnostics Tech (RADx Tech) fast track program, which supports the development and commercialization of innovative technologies to significantly increase the U.S. testing capacity for SARS-CoV-2, the virus that causes COVID-19. Read the NIH press release for additional information.

Back to all News

More Recent News

With COVID testing on the wane, small diagnostics companies shift focus

Small companies that won big testing contracts earlier in the pandemic are now seeing COVID-19 testing shift to the home. Next to big-name brands like Abbott Laboratories and Becton Dickinson, a swath of lesser-known companies are selling COVID-19 tests to schools, hospitals and corporations. Buoyed by the pandemic, these small firms and startups have seen…

COVID-19 won’t “end” – but it will be understood

At every point in the existence of any problem that humans have been faced with –  both ones we’ve solved, and ones we’re still working on – there was a time when that problem or challenge was completely new. And on the whole, we’ve figured out how to deal with most of them. The challenge…